Mark Wilterding insider trades
Open-market stock purchases and sales by Mark Wilterding, Chief Financial Officer at RxSight, Inc, from SEC Form 4 filings since Jan 12, 2026.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 5, 2026 | RXST RxSight, Inc | Sold (not open market) | $2.6M |
| Sep 5, 2026 | RXST RxSight, Inc | Bought (not open market) | $1.6M |
| Sep 2, 2026 | RXST RxSight, Inc | Sold | $54K |
| Aug 31, 2026 | RXST RxSight, Inc | Bought (not open market) | — |
| Aug 31, 2026 | RXST RxSight, Inc | Bought (not open market) | — |
| Feb 28, 2026 | RXST RxSight, Inc | Sold (not open market) | $61.4K |
| Feb 28, 2026 | RXST RxSight, Inc | Bought (not open market) | — |
| Jan 12, 2026 | RXST RxSight, Inc | Bought (not open market) | — |
| Jan 12, 2026 | RXST RxSight, Inc | Bought (not open market) | — |
Companies traded
- RXST RxSight, Inc: 1 sale, last Sep 5, 2026